Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Array Biopharma
Array Biopharma
(ARRY)
Array BioPharma is an American clinical stage, pharmaceutical company that focuses on oncology medication headquartered in Boulder, Colorado. The company is a subsidiary of Pfizer.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Braftovi
Encorafenib
2018-06-27
2029-2033
Colorectal neoplasms
,
Melanoma
Mektovi
Binimetinib
2018-06-27
2023-2033
Melanoma
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Binimetinib
colorectal neoplasms
,
colonic neoplasms
,
rectal neoplasms
,
gastrointestinal stromal tumors
,
disease progression
,
gene rearrangement
,
bcr-abl positive chronic myelogenous leukemia
,
lung neoplasms
,
non-small-cell lung carcinoma
,
melanoma
,
neoplasms
,
leukemia
,
myeloid leukemia
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
plexiform neurofibroma
,
neurofibromatosis 1
,
neurofibromatoses
,
neurofibroma
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
myeloid leukemia acute
,
biliary tract neoplasms
,
lymphoma
Encorafenib
neurofibromatosis 1
,
hereditary sensory and autonomic neuropathies
,
liver diseases
,
hepatic insufficiency
,
healthy volunteers/patients
,
non-small-cell lung carcinoma
,
brain neoplasms
,
lung neoplasms
,
renal cell carcinoma
,
pancreatic neoplasms
,
carcinoma
,
hairy cell leukemia
,
lymphatic metastasis
,
thyroid neoplasms
,
glioblastoma
,
glioma
,
gliosarcoma
,
astrocytoma
,
cutaneous malignant melanoma
,
multiple myeloma
,
plasma cell neoplasms
,
disease progression
,
hematologic neoplasms
,
pancreatic ductal carcinoma
,
immunotherapy
,
colorectal neoplasms
,
colonic neoplasms
,
neoplasm metastasis
,
adenocarcinoma
,
rectal neoplasms
,
skin neoplasms
,
gastrointestinal neoplasms
,
digestive system neoplasms
,
rectal diseases
,
gastrointestinal diseases
,
intestinal neoplasms
,
digestive system diseases
,
colonic diseases
,
intestinal diseases
,
skin diseases
,
biliary tract neoplasms
,
melanoma
,
neoplasms
,
hepatocellular carcinoma
,
liver neoplasms
,
gastrointestinal stromal tumors
,
neuroendocrine tumors
Ivuxolimab
lymphoma
,
follicular lymphoma
,
breast neoplasms
,
triple negative breast neoplasms
,
invasive hydatidiform mole
,
neoplasms
,
ovarian neoplasms
,
non-small-cell lung carcinoma
Utomilumab
neoplasms
Varlitinib
healthy volunteers/patients
,
breast neoplasms
,
carcinoma
,
hepatocellular carcinoma
,
cholangiocarcinoma
,
pancreatic neoplasms
,
neoplasms
,
biliary tract neoplasms
,
stomach neoplasms
,
bile duct neoplasms
,
gallbladder neoplasms
FILANESIB
multiple myeloma
,
paraproteinemias
,
plasmacytoma
,
plasma cell leukemia
,
leukemia
,
myeloid leukemia acute
,
myeloid leukemia
WNT-974
colorectal neoplasms
,
pancreatic neoplasms
,
triple negative breast neoplasms
,
squamous cell carcinoma of head and neck
,
melanoma
,
squamous cell carcinoma
,
esophageal squamous cell carcinoma
,
squamous cell neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use